Ripple Science Board of Directors Welcomes Jeanne Hecht, Clinical Trial Services Industry Veteran

March 30, 2021

This is an article about portfolio company, Ripple Science.

ANN ARBOR, Mich., March 30, 2021 /PRNewswire-PRWeb/ — Ripple Science, an emerging eClinical company servicing the clinical research site, life sciences and pharmaceutical services markets, announced today the appointment of Jeanne Hecht as a Non-Executive Director to the company effective immediately.

As CEO of JTH Consulting, LLC., Jeanne commands broad knowledge and deep expertise in the Life Sciences arena. She has dedicated much of her career to guiding international companies through healthy growth – thoughtfully, strategically, and with unyielding integrity. In addition to running her consulting practice, she serves as NED for a publicly-traded company out of the UK, Vectura Group (VEC).

View source version on iosconews.com: http://www.iosconews.com/news/state/article_4a15c1c1-552b-5ee2-87b3-7fffde36389b.html